Drugs that contain Bupivacaine

1. Drug name - EXPAREL

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11033495 PACIRA PHARMS INC Manufacturing of bupivacaine multivesicular liposomes Jan, 2041

(18 years from now)

US11179336 PACIRA PHARMS INC Manufacturing of bupivacaine multivesicular liposomes Jan, 2041

(18 years from now)

Treatment: Method of providing postsurgical pain management, for example, via infiltration for local analgesia or via interscalene brachial plexus nerve block for regional analgesia; Method of treating pain, for example, treating postsurgical pain via infiltration for local analgesia or via interscalene brachial plexus nerve block for regional analgesia

Dosage: INJECTABLE, LIPOSOMAL;INJECTION

More Information on Dosage
Strength Dosage Availability
133MG/10ML (13.3MG/ML) INJECTABLE, LIPOSOMAL;INJECTION Prescription
266MG/20ML (13.3MG/ML) INJECTABLE, LIPOSOMAL;INJECTION Prescription

2. Drug name - POSIMIR

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8153149 DURECT Controlled delivery system Sep, 2025

(2 years from now)

US8753665 DURECT Controlled delivery system Sep, 2025

(2 years from now)

US8846072 DURECT Controlled delivery system Sep, 2025

(2 years from now)

US8153661 DURECT Controlled delivery system Sep, 2025

(2 years from now)

Treatment: Method for providing sustained local anesthesia for at least 24 hours

Dosage: SOLUTION, EXTENDED RELEASE;INFILTRATION

More Information on Dosage
Strength Dosage Availability
660MG/5ML (132MG/ML) SOLUTION, EXTENDED RELEASE;INFILTRATION Discontinued

availability in other generic markets.

Click on the highlighted region to filter.